Übersicht unserer Publikationen

  • Raha S, Raud B, Oberdörfer L, Castro CN, Schreder A, Freitag J, Longerich T, Lochner M, Sparwasser T, Berod L*, Koenecke C*, Prinz I*. Disruption of de novo fatty acid synthesis via acetyl-CoA carboxylase 1 inhibition prevents acute graft-versus-host disease. Eur J Immunol. 2016 Jun 24. doi: 10.1002/eji.201546152. [Epub ahead of print] PubMed PMID: 27338930.*equal contribution
  • Lee CW, Wohlan K, Dallmann I, Förster R, Ganser A, Krueger A, Scherr M, Eder M, Koenecke C. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation. J Immunol. 2016 May 1;196(9):3927-34. doi: 10.4049/jimmunol.1502152.
  • Schreder M, Moschovakis GL, Halle S, Schlue J, Lee CW, Schippers A, David S, Bernhardt G, Ganser A, Pabst O, Förster R, Koenecke C. Differential effects of gut-homing molecules CC chemokine receptor 9 and integrin -beta7 during acute GvHD of the liver. Biol Blood Marrow Transplant. 2015 Sep 5. pii: S1083-8791(15)00599-6. [Epub ahead of print]
  • Scherr M, Elder A, Battmer K, Barzan D, Bomken S, Ricke-Hoch M, Schröder A, Venturini L, Blair HJ, Vormoor J, Ottmann O, Ganser A, Pich A, Hilfiker-Kleiner D, Heidenreich O, Eder M. Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia. Leukemia. 2014 Mar;28(3):554-65.
  • Schaller-Schönitz M, Barzan D, Williamson AJ, Griffiths JR, Dallmann I, Battmer K, Ganser A, Whetton AD, Scherr M, Eder M. BCR-ABL affects STAT5A and STAT5B differentially. PLoS One. 2014, May 16;9(5):e97243.
  • Koenecke C, Lee CW, Thamm K, Föhse L, Schafferus M, Mittrücker HW, Floess S, Huehn J, Ganser A, Förster R, Prinz I. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease. J Immunol. 2012 Sep 15;189(6):2890-6.
  • Koenecke C, Prinz I, Bubke A, Schreder A, Lee CW, Pabst O, Förster R. Shift of graft-versus-host-disease target organ tropism by dietary vitamin A. PLoS One. 2012;7(5):e38252.
  • Surdziel E, Cabanski M, Dallmann I, Lyszkiewicz M, Krueger A, Ganser A, Scherr M, Eder M. Enforced expression of miR-125b affects myelopoiesis by targeting multiple signaling pathways. Blood. 2011 Apr 21;117(16):4338-48.
  • Seth S, Ravens I, Lee CW, Glage S, Bleich A, Förster R, Bernhardt G, Koenecke C. Absence of CD155 aggravates acute graft-versus-host disease. Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):E32-3.
  • Koenecke C, Czeloth N, Bubke A, Schmitz S, Kissenpfennig A, Malissen B, Huehn J, Ganser A, Förster R, Prinz I. Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. Eur J Immunol. 2009 Nov;39(11):3091-6.
  • Ghosh A, Koestner W, Hapke M, Schlaphoff V, Länger F, Baumann R, Koenecke C, Cornberg M, Welte K, Blazar BR, Sauer MG. Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras. Blood. 2009 Apr 30;113(18):4440-8.
  • Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU, Ganser A, Eder M*, Scherr M*. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood. 2007; 109:4399-405 (* equal contribution)